Literature DB >> 5314224

[Indication for immunosuppression in aggressive chronic hepatitis].

K O Vorlaender, H Henning, C J Lüders.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5314224     DOI: 10.1007/BF01492050

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  8 in total

1.  [The histological picture of chronic-aggressive hepatitis in immunosuppressive therapy].

Authors:  E Förster; D Maas; K Beck; W Oehlert; F Birnbaum
Journal:  Dtsch Med Wochenschr       Date:  1971-01-01       Impact factor: 0.628

2.  [Immunology of chronic inflammatory liver diseases].

Authors:  K O Vorlaender
Journal:  Dtsch Med J       Date:  1969-08

3.  [Australia-SH antigen and liver diseases].

Authors:  O Krassnitzky; F Pesendorfer; F Wewalka
Journal:  Dtsch Med Wochenschr       Date:  1970-02-06       Impact factor: 0.628

4.  [Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents].

Authors:  D Schmähl; H Osswald
Journal:  Arzneimittelforschung       Date:  1970-10

5.  [Immunosuppressive effect of cytostatics in the clinic].

Authors:  H Gerhartz
Journal:  Schweiz Rundsch Med Prax       Date:  1970-07-21

6.  [Long term and permanent therapy of chronic hepatitis].

Authors:  K Becker
Journal:  Monatsschr Kinderheilkd       Date:  1970-08

Review 7.  [Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].

Authors:  G L Floersheim
Journal:  Schweiz Med Wochenschr       Date:  1970-12-26

8.  Australia antigen and hepatitis. Studies in asymptomatic people and lepromatous leprosy patient.

Authors:  B S Blumberg; L Melartin
Journal:  Arch Intern Med       Date:  1970-02
  8 in total
  1 in total

1.  [Studies on the effects of azathioprine, choline orotate and phenobarbital on enzymes of the endoplasmatic reticulum and mitochondria of rat liver].

Authors:  G Brunner; I Vido; E Perings; H Grünewälder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.